Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0000950170-24-026365 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2024-03-05 | 2024-03-01+ | TYRA | Bensen Daniel | COO | S - Sale | $20.06 | -9,152 | 434.9K | -2% | -$183.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-05 | S | D | 1,189 | $20.02 | 433,684 | D | — | — | (F4) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.10. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 2 | Common | Common Stock | 2024-03-01 | S | D | 2,900 | $20.04 | 439,936 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.14. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 3 | Common | Common Stock | 2024-03-04 | S | D | 5,063 | $20.08 | 434,873 | D | — | — | (F3) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.44. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |